Distribution of neuroendocrine cells in the small and large intestines of the one-humped camel (Camelus dromedarius).
The distribution and relative frequency of neuroendocrine cells in the small and large intestines of one-humped camel were studied using antisera against 5-hydroxytryptamine (5-HT), cholecystokinin (CCK-8), somatostatin (SOM), peptide tyrosine tyrosine (PYY), gastric inhibitory polypeptide (GIP), neuronal nitric oxide synthase (nNOS), gastrin releasing peptide (GRP), substance P (SP), and neurokinin A (NKA). Among these cell types, CCK-8 immunoreactive (IR) cells were uniformly distributed in the mucosa, while others showed varied distribution in the villi or crypts of the small intestine. Immunoreactive cells like 5HT, CCK-8, and SOM showed peak density in the villi and crypts of the small intestine and in the colonic glands of the large intestine, while cells containing SP were discerned predominately in the crypts. 5-HT, CCK-8 and SOM cells were mainly flask-shaped and of the open-variety, while PYY and SP immunoreactive cells were mainly rounded or basket-shaped and of the closed variety. Basically the distribution pattern of the endocrine cells in the duodenum, jejunum and colon of the one-humped camel is similar to that of other mammals. Finally, the distribution of these bioactive agents may give clues as to how these agents aid in the function of the intestinal tract of this desert animal.
Ali
M Al Haj
MA
Department of Pharmacology, Faculty of Medicine and Health Sciences, UAE University, PO Box 17666, Al Ain, United Arab Emirates. mahmoud_alhaj@hotmail.com
Nyberg
Fred
F
Chandranath
S I
SI
Dhanasekaran
S
S
Tariq
Saeed
S
Petroianu
G
G
Hasan
M Y
MY
Adeghate
Ernest A
EA
Adem
A
A
D000818:Animals; D002162:Camelus; D002766:Cholecystokinin / Q000032:analysis; D005749:Gastric Inhibitory Polypeptide / Q000032:analysis; D019886:Gastrin-Releasing Peptide / Q000032:analysis; D007150:Immunohistochemistry; D007420:Intestine, Large / Q000166:cytology / Q000502:physiology*; D007421:Intestine, Small / Q000166:cytology / Q000502:physiology*; D015288:Neurokinin A / Q000032:analysis; D052250:Nitric Oxide Synthase Type III / Q000032:analysis; D012701:Serotonin / Q000032:analysis*; D012844:Sincalide / Q000032:analysis; D013004:Somatostatin / Q000032:analysis; D013373:Substance P / Q000032:analysis
D012701:Serotonin; D013373:Substance P; D013004:Somatostatin; D005749:Gastric Inhibitory Polypeptide; D019886:Gastrin-Releasing Peptide; D015288:Neurokinin A; D002766:Cholecystokinin; D052250:Nitric Oxide Synthase Type III; D012844:Sincalide